Additionally, Blennow and colleagues developed a MS method to simultaneously quantify tau peptides in plasma, indicating that pTau217, pTau231 and pTau205 are the plasma tau forms that best reflect AD-related brain pathological changes and further supporting its potential as a diagnostic tool (96, 106, 107). The gene discussed is MAPT; the disease is Alzheimer disease.